Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Rybak

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Antimicrobial Agents and Chemotherapy|June 1, 1992
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplaninM J Rybak, E M Bailey, L H Warbasse
Antimicrobial Agents and Chemotherapy|August 1, 1991
Clinical evaluation of teicoplanin fluorescence polarization immunoassayM J Rybak, E M Bailey, V N Reddy
The Annals of Pharmacotherapy|October 1, 1993
Enterococcus, an emerging pathogenS A Tailor, E M Bailey, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J Rybak
Clinical Pharmacy|February 1, 1989
Enoxacin: a new fluoroquinoloneL A Jaber, E M Bailey, M J Rybak
Drug Intelligence & Clinical Pharmacy|June 1, 1984
Sensitivity testing and the inoculum effectS R Erickson, S A Hunt, M J Rybak
The Annals of Pharmacotherapy|May 1, 1994
Oral treatment of gonorrhea and chlamydiaK A Loughlin, C M Bakst, M J Rybak
Antimicrobial Agents and Chemotherapy|September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro modelB J McGrath, K C Lamp, M J Rybak
Antimicrobial Agents and Chemotherapy|May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniaeE A Coyle, G W Kaatz, M J Rybak
Pharmacotherapy|November 23, 2001
Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and reviewA L Kwa, V H Tam, M J Rybak
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|June 1, 1992
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplaninM J Rybak, E M Bailey, L H Warbasse
Antimicrobial Agents and Chemotherapy|August 1, 1991
Clinical evaluation of teicoplanin fluorescence polarization immunoassayM J Rybak, E M Bailey, V N Reddy
The Annals of Pharmacotherapy|October 1, 1993
Enterococcus, an emerging pathogenS A Tailor, E M Bailey, M J Rybak
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J Rybak
Clinical Pharmacy|February 1, 1989
Enoxacin: a new fluoroquinoloneL A Jaber, E M Bailey, M J Rybak
Drug Intelligence & Clinical Pharmacy|June 1, 1984
Sensitivity testing and the inoculum effectS R Erickson, S A Hunt, M J Rybak
The Annals of Pharmacotherapy|May 1, 1994
Oral treatment of gonorrhea and chlamydiaK A Loughlin, C M Bakst, M J Rybak
Antimicrobial Agents and Chemotherapy|September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro modelB J McGrath, K C Lamp, M J Rybak
Antimicrobial Agents and Chemotherapy|May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniaeE A Coyle, G W Kaatz, M J Rybak
Pharmacotherapy|November 23, 2001
Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and reviewA L Kwa, V H Tam, M J Rybak
Pageof 14